Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mastermind-like 1 pseudogene (ENSG00000276951) is a nonfunctional genomic DNA sequence derived from or highly homologous to the functional mastermind-like 1 (MAML1) gene. Pseudogenes do not produce functional proteins due to disabling mutations (such as premature stop codons, frameshifts, or the absence of regulatory elements) and typically serve no direct biological function. In rare cases, transcripts from pseudogenes can have regulatory effects (e.g., via non-coding RNAs), but there is no evidence that this pseudogene plays an active role in biology or disease. Pseudogenes like this can sometimes interfere with molecular assays (such as PCR) due to sequence similarity with their parent gene, but this is not unique to this specific pseudogene[1][3][5]. Pseudogenes are classified as a distinct molecular family because they retain high similarity to functional genes but lack protein-coding capacity[1][3]. Most human pseudogenes are not transcribed or produce only nonfunctional RNAs; some exceptions exist where pseudogene transcripts modulate gene expression regulatory networks in cancer or development, but these instances are uncommon and not demonstrated for this specific target[5]. The entry "ENSG00000276951" is the Ensembl identifier; there is no evidence from current reference resources that this is anything other than a processed or duplicated (nonfunctional) pseudogene. In summary, "mastermind-like 1 pseudogene" is a pseudogene, not a protein-coding gene or druggable target, and should not be considered a functional molecule in therapeutic contexts[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mastermind-like 1 pseudogene.